MDxHealth Operating Cycle from 2010 to 2026
| MDXH Stock | USD 3.50 0.06 1.69% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 114.26 | Current Value 108.55 | Quarterly Volatility 110.66459291 |
Check MDxHealth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MDxHealth's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.7 M, Interest Expense of 9.2 M or Selling General Administrative of 66.4 M, as well as many indicators such as Price To Sales Ratio of 1.4, Dividend Yield of 0.0 or PTB Ratio of 7.34. MDxHealth financial statements analysis is a perfect complement when working with MDxHealth Valuation or Volatility modules.
MDxHealth | Operating Cycle | Build AI portfolio with MDxHealth Stock |
The Operating Cycle trend for MDxHealth SA ADR offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether MDxHealth is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest MDxHealth's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of MDxHealth SA ADR over the last few years. It is MDxHealth's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MDxHealth's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
MDxHealth Operating Cycle Regression Statistics
| Arithmetic Mean | 219.91 | |
| Geometric Mean | 195.17 | |
| Coefficient Of Variation | 50.32 | |
| Mean Deviation | 91.99 | |
| Median | 237.59 | |
| Standard Deviation | 110.66 | |
| Sample Variance | 12,247 | |
| Range | 393 | |
| R-Value | (0.79) | |
| Mean Square Error | 4,879 | |
| R-Squared | 0.63 | |
| Significance | 0.0002 | |
| Slope | (17.35) | |
| Total Sum of Squares | 195,946 |
MDxHealth Operating Cycle History
About MDxHealth Financial Statements
Investors use fundamental indicators, such as MDxHealth's Operating Cycle, to determine how well the company is positioned to perform in the future. Although MDxHealth's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 114.26 | 108.55 |
Currently Active Assets on Macroaxis
When determining whether MDxHealth SA ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MDxHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mdxhealth Sa Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mdxhealth Sa Adr Stock:Check out the analysis of MDxHealth Correlation against competitors. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is there potential for Biotechnology market expansion? Will MDxHealth introduce new products? Factors like these will boost the valuation of MDxHealth. Expected growth trajectory for MDxHealth significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about MDxHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.52) | Revenue Per Share | Quarterly Revenue Growth 0.177 | Return On Assets | Return On Equity |
The market value of MDxHealth SA ADR is measured differently than its book value, which is the value of MDxHealth that is recorded on the company's balance sheet. Investors also form their own opinion of MDxHealth's value that differs from its market value or its book value, called intrinsic value, which is MDxHealth's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because MDxHealth's market value can be influenced by many factors that don't directly affect MDxHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that MDxHealth's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MDxHealth represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, MDxHealth's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.